1. Home
  2. XBIT vs SSP Comparison

XBIT vs SSP Comparison

Compare XBIT & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.51

Market Cap

75.0M

Sector

Health Care

ML Signal

HOLD

Logo E.W. Scripps Company (The)

SSP

E.W. Scripps Company (The)

HOLD

Current Price

$3.43

Market Cap

449.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
SSP
Founded
2005
1878
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
75.0M
449.7M
IPO Year
2015
1998

Fundamental Metrics

Financial Performance
Metric
XBIT
SSP
Price
$2.51
$3.43
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.95
AVG Volume (30 Days)
22.3K
655.5K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,150,585,000.00
Revenue This Year
N/A
$8.34
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$2.02
52 Week High
$3.61
$5.39

Technical Indicators

Market Signals
Indicator
XBIT
SSP
Relative Strength Index (RSI) 57.10 31.65
Support Level $2.15 $3.27
Resistance Level $2.69 $3.95
Average True Range (ATR) 0.08 0.34
MACD -0.01 -0.19
Stochastic Oscillator 49.79 0.57

Price Performance

Historical Comparison
XBIT
SSP

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

Share on Social Networks: